Newfeed

—Patients Treated with ARIKAYCE Plus Macrolide-Based Background Regimen Had Meaningfully Greater Improvements in Respiratory Symptoms vs. Macrolide-Based Background Regimen Alone, As Measured By the QOL-B Respiratory Domain Instrument— —QOL-B Respiratory Domain Scores for ARIKAYCE Patients Sho

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: